Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03250338
Title	Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
Recruitment	Unknown status
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Arog Pharmaceuticals, Inc.
Indications	acute myeloid leukemia
Therapies	Cytarabine + Filgrastim + Fludarabine + Idarubicin + Mitoxantrone Crenolanib + Cytarabine + Filgrastim + Fludarabine + Idarubicin + Mitoxantrone
Age Groups:	senior \| adult
Covered Countries	USA \| ITA \| FRA \| ESP \| DEU \| CAN